These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26432935)

  • 1. Reply by Authors.
    J Urol; 2016 Jan; 195(1):225. PubMed ID: 26432935
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis: M. A. Liss, W. Kim, D. Moskowitz and R. J. Szabo J Urol 2015;194:397-402.
    Wagenlehner F
    J Urol; 2016 Jan; 195(1):224-5. PubMed ID: 26432938
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin Resistance: A Review of Patients in East London Undergoing Prostate Biopsy.
    Turner B; Pati J; Nargund V; Claxton A; Longstaff V; Sarkar S; Green J
    Urol Nurs; 2016; 36(4):173-82. PubMed ID: 29240328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
    Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.
    Losco G; Studd R; Blackmore T
    BJU Int; 2014 Mar; 113 Suppl 2():69-72. PubMed ID: 24894854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply by authors.
    J Urol; 2014 Mar; 191(3):872-3. PubMed ID: 24360871
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply by authors.
    J Urol; 2013 Oct; 190(4):1444. PubMed ID: 23886876
    [No Abstract]   [Full Text] [Related]  

  • 10. Pokes, pathogens, and primum non nocere: prudent prophylaxis protocols for prostate biopsy.
    Drawz SM; Johnson JR
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):977-9. PubMed ID: 23917914
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment.
    Djavan B; Kazzazi A
    Urology; 2011 May; 77(5):1041-2; author reply 1042. PubMed ID: 21539955
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
    Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
    Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy.
    Schaeffer AJ
    BJU Int; 2013 May; 111(6):853-4. PubMed ID: 23615027
    [No Abstract]   [Full Text] [Related]  

  • 16. Words of wisdom. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Bartoletti R; Cai T
    Eur Urol; 2015 Mar; 67(3):591-2. PubMed ID: 25760414
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry.
    Johansen TEB; Zahl PH; Baco E; Bartoletti R; Bonkat G; Bruyere F; Cai T; Cek M; Kulchavenya E; Köves B; Mouraviev V; Pilatz A; Tandogdu Z; Tenke P; Wagenlehner FME
    World J Urol; 2020 Jan; 38(1):17-26. PubMed ID: 31183524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: O. Kehinde, M. Al-Maghrebi, M. Sheikh and J. T. Anim J Urol 2013; 189: 911–915.
    Ozgur BC; Sarici H; Doluoglu OG; Telli O; Eroglu M
    J Urol; 2014 Mar; 191(3):871-3. PubMed ID: 24360872
    [No Abstract]   [Full Text] [Related]  

  • 19. Urosepsis and bacteraemia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy.
    Hadway P; Barrett LK; Waghorn DJ; Hasan K; Bdesha A; Haldar N; Kelleher J
    BJU Int; 2009 Dec; 104(11):1556-8. PubMed ID: 20053186
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: E. O. Kehinde, M. Al-maghrebi, M. Sheikh and J. T. Anim J Urol 2013, 189: 911-915.
    Gaylis F; Fink L
    J Urol; 2013 Oct; 190(4):1443-4. PubMed ID: 23623974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.